EMD-62788

Single-particle
2.7 Å
EMD-62788
3D View Gallery
Deposition: 19/12/2024
Map released: 11/03/2026
Last modified: 11/03/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-62788
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 9l3q summary report (pdf.gz) Map and 9l3q FULL report (pdf.gz)
EMICSS annotations (xml)

Cryo-EM structure of SARS-CoV-2 PT Spike Protein complex with a potent broad-spectrum macrocyclic peptide inhibitor 6L3-3P11K

EMD-62788

Single-particle
2.7 Å
EMD-62788
3D View Gallery
Deposition: 19/12/2024
Map released: 11/03/2026
Last modified: 11/03/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, synthetic construct
Sample: SARS-CoV-2 PT Spike Protein complex with a potent broad-spectrum macrocyclic peptide inhibitor 6L3-3P11K
Fitted models: 9l3q

Deposition Authors: Wang M, Yang JY, Peng Q, Shi Y
Intranasal administration of broad-spectrum macrocyclic peptide inhibitor protects against SARS-CoV-2 Omicron variants.
Wang M, Yang J, Tan Y, Yuan S , Shi G, Peng Q, Li Y, Poon VK , Chan CC , Xiao N, Zhang AJ , Xie Y, Li J , Luo H, Fu Y, Chen Y, Compton AA , Zhang Y , Yang Y , Gao GF , Hou H , Chan JF , Yin Y , Shi Y
(2026) Nat Commun , 17 , 1753 - 1753
PUBMED: 41587975
DOI: doi:10.1038/s41467-026-68462-9
ISSN: 2041-1723